Amir Lahav, ScD
Digital Health and DTx Advisor, Lahav Consulting
Digital TherapeuticsAmir shares expert analysis on clinical evidence generation, pharma collaboration with DTx companies, and the translation of digital biomarkers into clinical trials.
Digital Medicine / Pharma Partnerships / Clinical Development
Best for: Pharma innovators and digital medicine researchers
Anand Iyer, PhD
Chief Digital Officer, Welldoc
Digital TherapeuticsAnand offers valuable strategies for scaling digital therapeutic solutions for chronic diseases, focusing on clinical integration, patient engagement, and reimbursement models.
Chronic Disease Management / Digital Health / DTx Commercialization
Best for: Digital health product leaders and health system executives
Andy Molnar
Chief Executive Officer, Digital Therapeutics Alliance
Digital TherapeuticsHe provides regular updates on digital therapeutics legislation, payer coverage decisions, and efforts to integrate clinically validated software into mainstream healthcare.
DTx Advocacy / Healthcare Policy / Market Access
Best for: Market access leads and digital health founders
Dmitry Popolov
Digital Therapeutics Analyst, Independent Consultant
Digital TherapeuticsDmitry curates comprehensive global updates on digital therapeutic regulatory approvals, funding rounds, and clinical trial results, saving followers hours of research.
DTx Market Intelligence / Regulatory Frameworks / Industry Trends
Best for: Industry researchers and venture capital analysts
Eugene Borukhovich
Co-founder and Chief Operating Officer, YourCoach Health
Digital TherapeuticsEugene hosts discussions and posts extensively about the digital health ecosystem, including how digital coaching and digital therapeutics intersect to improve patient outcomes.
Digital Health coaching / Health Tech Startups / DTx Integration
Best for: Healthcare entrepreneurs and digital coaches
Jessica Shull, PhD
Digital Health Advisor and Researcher, VictoRx
Digital TherapeuticsShe provides a critical European perspective on digital therapeutics, analyzing policies like Germany's DiGA and France's PECAN reimbursement frameworks.
European Regulation / DTx Reimbursement / Global Health Technology
Best for: European digital health developers and policy analysts
Marty Culjat, PhD
SVP of Digital Medicine and DTx, EVERSANA
Digital TherapeuticsMarty shares practical advice on how to commercialize digital therapeutics, navigate regulatory hurdles, and gain clinical adoption from providers.
Commercialization / Medical Affairs / Regulatory Strategy
Best for: Regulatory affairs professionals and commercial teams
Megan Coder, PharmD
Chief Policy Officer, Digital Therapeutics Alliance
Digital TherapeuticsReaders gain deep insights into global regulatory pathways, reimbursement policies, and clinical evidence standards shaping the digital therapeutics industry.
Digital Therapeutics Policy / DTx Regulation / Global Market Access
Best for: DTx executives and regulatory policy experts
Owen McCarthy
Co-founder and President, MedRhythms
Digital TherapeuticsFollow Owen for insights on developing prescription digital therapeutics that use music and technology to improve walking and rehabilitation in neurologic populations.
Neurorehabilitation / Digital Therapeutics / Entrepreneurship
Best for: Medtech entrepreneurs and rehabilitation specialists
Shaheen Lakhan, MD, PhD
Chief Medical Officer, Click Therapeutics
Digital TherapeuticsDr. Lakhan shares clinical perspectives on the intersection of neurology, psychiatry, and software-driven medical interventions. He details how digital therapeutics are validated and prescribed.
Neurotherapeutics / Digital Medicine / Clinical Trials
Best for: Clinicians and clinical trial managers
Showing 10 of 121 people. Listings are editorial, not paid, and nobody pays to appear here.